Single-pathway
Semaglutide
A GLP-1 receptor agonist — the same active ingredient as Ozempic and Wegovy. Excellent for steady, sustainable loss and stronger appetite control.
- • Weekly subcutaneous injection
- • ~15% average total body weight reduction
- • Ideal for first-time GLP-1 patients
Pay in full · 3 months
$145/mo
$435 billed once · 3-month supply
Month to month
$185/mo
Billed monthly · cancel anytime


